Peptide Therapy Side Effects and Safety Profile: What 2025 Research Shows Common Peptide Therapy Side Effects (Generally Mild): Injection site reactions: redness, swelling, bruising (affects 15-30% of users) Temporary nausea or headaches (first 1-2 weeks) Increased appetite with growth hormone peptides Fluid retention in hands/feet (rare, resolves with dosage adjustment) Fatigue during initial adaptation phase Who Should Avoid Peptide Therapy: Pregnant or breastfeeding women (insufficient safety data) Active cancer patients (growth-promoting peptides may stimulate cell proliferation) Severe kidney or liver disease without medical clearance Anyone without qualified physician supervision FDA Approved vs
1 Introduction Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the rate-limiting first step in the pentose phosphate pathway (PPP), converting nicotinamide adenine dinucleotide phosphate (NADP) to its reduced form: NADPH ( Figure 1A )
Zinc also specifically protects tissue barriers in the body and helps prevent foreign pathogens from entering Zinc is the second most prevalent mineral in your body after iron, and certain amounts of zinc are necessary for proper development and growth
These phytochemicals highlight the therapeutic potential of dietary interventions in alleviating IC symptoms and enhancing bladder resilience (Yu et al., 2024)
The biggest problem is that there are few to no sublingual tablet NMN studies to rely on for dosing clarity
